Abstract:Extensive efforts have been devoted to the development of near-infrared (NIR) dye-based imaging probes and/or photothermal agents for cancer theranostics in vivo. However, the intrinsic chemical instability and self-aggregation properties of NIR dyes in physiological condition limit their widely applications in the pre-clinic study in living animals. Squaraine dyes are among the most promising NIR fluorophores with high absorption coefficiencies, bright fluorescence and photostability. By introducing dicyanovinyl groups into conventional squaraine (SQ) skeleton. These acceptor-substituted SQ dyes not only show superior NIR fluorescence properties (longer wavelength, higher quantum yield) but also exhibit more chemical robustness. In this work, we demonstrated highly stable and biocompatible supramolecular adducts of SQ and the natural carrier protein, i.e., bovine serum albumin (BSA) (SQ⊂BSA) for tumor targeted imaging and photothermal therapy in vivo. SQ was selectively bound to BSA hydrophobic domain via hydrophobic and hydrogen bonding interactions with up to 80-fold enhanced fluorescence intensity. By covalently conjugating target ligands to BSA, the SQ⊂BSA was capable of targeting tumor sites and allowed for monitoring the time-dependent biodistribution of SQ⊂BSA, which consequently determined the protocol of photothermal therapy in vivo. We envision that this supramolecular strategy for selectively binding functional imaging agents and/or drugs into human serum albumin might potentially utilize in the preclinical and even clinic studies in the future.

Quasi-dendritic sulfonate-based organic small molecule for high-quality NIR-II bone-targeted imaging

Azide-Dye Unexpected Bone Targeting for Near-Infrared Window II Osteoporosis Imaging

In Vivo Live Imaging of Bone Using Shortwave Infrared Fluorescent Quantum Dots

Near-Infrared Contrast Agents for Bone-Targeted Imaging

A novel small-molecule near-infrared II fluorescence probe for orthotopic osteosarcoma imaging

Bone disease imaging through the near-infrared-II window

Synthesis and Evaluation of a Novel 99mtc Nitrido Radiopharmaceutical with Alendronate Dithiocarbamate As a Potential Bone‐imaging Agent

An NIR-II Probe with High PSMA Affinity Demonstrates an Unexpected Excellent Bone Imaging Ability

Quaternary Ammonium Salt Based NIR‐II Probes for In Vivo Imaging

Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo

Specific Small-Molecule NIR-II Fluorescence Imaging of Osteosarcoma and Lung Metastasis.

Nanoparticles Passive Targeting Allows Optical Imaging of Bone Diseases

Novel Small-Molecule Fluorophores for in Vivo NIR-IIa and NIR-IIb Imaging.

A high quantum yield molecule-protein complex fluorophore for near-infrared II imaging

Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones

NIR-II Ratiometric Lanthanide-Dye Hybrid Nanoprobes Doped Bioscaffolds for In Situ Bone Repair Monitoring

Precise Diagnosis and Therapy of Bone Cancer Using Near-Infrared Lights

Carbonic Anhydrase Inhibitor-decorated Semiconducting Oligomer Nanoparticles for Active-Targeting NIR-II Fluorescence Tumor Imaging

Development of superior bone scintigraphic agent from a series of (99m)Tc-labeled zoledronic acid derivatives

Biodegradable Silica-Based Nanotheranostics for Precise MRI/NIR-II Fluorescence Imaging and Self-Reinforcing Antitumor Therapy

Anti-quenching NIR-II molecular fluorophores for in vivo high-contrast imaging and pH sensing